FDA Inspection 1123169 — Prof. Dr. Stephanie Krueger
The FDA completed an inspection of Prof. Dr. Stephanie Krueger on March 6, 2020 in Berlin. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 6, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Berlin (Germany)
Additional Details
Clinical Investigator (CI)